Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

0 Views· 09/18/23
OncLive® On Air
OncLive® On Air
0 Subscribers
0
In Drama

Drs Jones and Somaiah discuss unmet needs in GIST that the Peak trial seeks to answer; the advantages of the methods and design of this trial; and how the tolerable safety profile of bezuclastinib plus sunitinib supports further research with this combination.

Show more

 0 Comments sort   Sort By


Up next